Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- GALTON D. A. Myleran in chronic myeloid leukaemia; results of treatment. Lancet. 1953 Jan 31;264(6753):208–213. doi: 10.1016/s0140-6736(53)90885-x. [DOI] [PubMed] [Google Scholar]
- GARDIKAS C., WILKINSON J. F. Trial of beta-naphthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders. Lancet. 1951 Jan 20;1(6647):137–139. doi: 10.1016/s0140-6736(51)91214-7. [DOI] [PubMed] [Google Scholar]
- KARNOFSKY D. A., BURCHENAL J. H., ARMISTEAD G. C., Jr, SOUTHAM C. M., BERNSTEIN J. L., CRAVER L. F., RHOADS C. P. Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use. AMA Arch Intern Med. 1951 Apr;87(4):477–516. doi: 10.1001/archinte.1951.03810040002001. [DOI] [PubMed] [Google Scholar]
- NABARRO J. D. N. Nitrogen mustard therapy with special reference to Hodgkin's disease. Br Med J. 1949 Sep 17;2(4628):622–625. doi: 10.1136/bmj.2.4628.622. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PATERSON E., BOLAND J. Triaethyleneimino-s-triazine in human malignant disease: a preliminary trial. Br J Cancer. 1951 Mar;5(1):28–37. doi: 10.1038/bjc.1951.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROSE F. L., HENDRY J. A., WALPOLE A. L. New cytotoxic agents with tumour-inhibitory activity. Nature. 1950 Jun 24;165(4208):993–996. doi: 10.1038/165993a0. [DOI] [PubMed] [Google Scholar]
- WILKINSON J. F. Folic acid. Br Med J. 1948 Apr 24;1(4555):771–passim. doi: 10.1136/bmj.1.4555.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WILKINSON J. F., GARDIKAS C. Treatment of acute leukemia with aminopterin. Lancet. 1951 Feb 10;1(6650):325–327. doi: 10.1016/s0140-6736(51)92298-2. [DOI] [PubMed] [Google Scholar]